from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0981/mprA

LFCtreatmentdescriptionclass of inhibitor

-0.274

Amikacinug/mL Amikacintranslation

-0.124

Cap5-10ug/mL Capreomycintranslation

-0.664

Rox10-50 ug/mL Roxithromycintranslation

-0.625

SM2-5 ug/mL Streptomycintranslation

-0.134

Tet5-10 ug/mL Tetracyclinetranslation

0.183

Rif0.2-5ug/mL Rifampicintranscription

-0.429

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.408

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.622

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.803

CPZ10-50 ug/mL Chlorpromazinerespiration

1.462

Clofazimine10-13 ug/mL Clofaziminerespiration

0.582

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.074

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.248

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.590

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.574

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

2.540

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.975

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.572

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.305

KCN5-20 ug/mL Potassium cyaniderespiration

0.597

NaN30.2-2 mM Sodium aziderespiration

0.502

Nigericin50 uM Nigericinrespiration

0.138

TRC10-150 ug/mL Triclosanrespiration

2.130

TRZ10-25 ug/mL Thioridazinerespiration

0.210

Valinomycin0.5-10 uM Valinomycinrespiration

0.258

ZnSO42 mM ZnSO4respiration

0.543

menadione6-10 ug/mL Menadionerespiration

0.004

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.590

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.001

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.111

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.866

NRP_1Non-replicating persistence stage 1dosRassociated

-0.504

Amp0.2mg/mL AmpicillincellWall

-0.184

Cephalexin20-100 ug/mL CephalexincellWall

-0.522

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.235

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.475

EMB10-20 ug/mL EthambutolcellWall

-0.644

Eta12-40 ug/mL EthionamidecellWall

-0.601

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.402

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.050

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.285

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.903

BZA0.12 mg/mL BenzamidearomaticAmides

-0.753

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.938

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.548

H2O24 mM hydrogen peroxideDNAdamaging

-0.346

Levo10 ug/mL LevofloxacinDNAdamaging

-0.897

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.047

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.336

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.779

UVUV-irradiationDNAdamaging

0.532

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.097

Antimycin12.5-50 ug/mL Antimycin A?

-0.248

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.059

PA_110-50 ug/mL Antitubercular compound PA-1?

0.423

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.586

PA8240.2-2 ug/mL PA-824?

0.425

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.011

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.447

Verapamil50 uM Verapamil?

-0.044

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.578

methoxatin10-20 ug/mL Methoxatin?